congress
presentations
29th Nevada Psychiatric Association National Psychopharmacology Update
Las Vegas, NV
February 14-17, 2024
AXS-05 | Major Depressive Disorder
Efficacy, Tolerability, and Safety of AXS-05, a Novel Oral Antidepressant: Data from 3 Clinical Trials
view/download
AXS-05 | Major Depressive Disorder
Impact of AXS-05, an Oral NMDA Receptor Antagonist, on Anhedonic Symptoms in Major Depressive Disorder
view/download